Counseling the patient with prostate cancer
Bissada, N.K.
Journal of the Arkansas Medical Society 105(3): 66
2008
ISSN/ISBN: 0004-1858 PMID: 18828476 Document Number: 628236
Document emailed within 1 workday
Related Documents
Woodson, A.H. 2019: Genetic counseling considerations for men with prostate cancer Canadian Journal of Urology 26(5 Suppl 2: 40-41Teodorovich, O.V.; Shatokhin, M.N.; Naryshkin, S.A.; Abdullayev, M.I.; Krasnov, A.V.; Borisenko, G.G.; Zhurbenko, A.A. 2019: Focal laser coagulation in the treatment of a patient with kidney cancer and prostate cancer Urologiia 2: 55-58
Cassileth, B.R.; Berlyne, D. 1989: Counseling the cancer patient who wants to try unorthodox or questionable therapies Oncology 3(4): 29-33; Discussion 34 40-1
Kommers, M.S.; Sullivan, M.D.; Yonkers, A.J. 1977: "Practical suggestions on counseling how i do it": counseling the laryngectomized patient Laryngoscope 87(11): 1961-1965
Ward-Smith, P. 2003: Brachytherapy for prostate cancer: the patient's perspective Urologic Nursing 23(3): 213-217
Murray, N.P.; Aedo, S.óc.; Reyes, E.; Fuentealba, C.; Jacob, O. 2019: Primary circulating prostate cells, age and prostatic volumen predict the presence of prostate cancer in men with indication of a second prostate biopsy Archivos Espanoles de Urologia 72(1): 16-24
Romppanen, J.; Haapalainen, T.; Punnonen, K.; Penttilä, I. 2002: Serum sialic acid and prostate-specific antigen in differential diagnosis of benign prostate hyperplasia and prostate cancer Anticancer Research 22(1a): 415-420
Moul, J.W.; Saad, F. 2005: Low-risk prostate cancer patient: active treatment Canadian Journal of Urology 12(Suppl 2): 25-27
Vis, A.é N.; van Moorselaar, R.J.A. 2019: Androgen receptor inhibitors in prostate cancer: new drugs, but for which patient? Nederlands Tijdschrift Voor Geneeskunde 163
Sun, S.-C.; Zhao, H.; Liu, R.; Wang, B.-L.; Liu, Y.-Q.; Zhao, Y.; Shi, Z.-D. 2017: Expression of long non-coding RNA H19 in prostate cancer and its effect on the proliferation and glycometabolism of human prostate cancer cells Zhonghua Nan Ke Xue 23(2): 120-124
Considine, B.; Petrylak, D.P. 2019: Integrating Novel Targets and Precision Medicine into Prostate Cancer Care-Part 1: the Non-Androgen-Targetable Pathways in Castration-Resistant Prostate Cancer Oncology 33(3): 113-118
Grosclaude, P.; Menegoz, F.; Schaffer, P.; Macé Lesec'h, J.; Arveux, P.; Le Mab, G.; Soulié, M.; Villers, A. 1997: Prostate cancer screening (II): is prostate cancer a public health problem? Update of incidence and mortality figures in France from 1982 to 1990 Progres en Urologie: Journal de l'Association Francaise d'Urologie et de la Societe Francaise d'Urologie 7(4): 647-654
Hanisch, L.J.; Palmer, S.C.; Marcus, S.C.; Hantsoo, L.; Vaughn, D.J.; Coyne, J.C. 2009: Comparison of objective and patient-reported hot flash measures in men with prostate cancer Journal of Supportive Oncology 7(4): 131-135
Ragde, H.; Grado, G.L.; Nadir, B.S. 2001: Brachytherapy for clinically localized prostate cancer: thirteen-year disease-free survival of 769 consecutive prostate cancer patients treated with permanent implants alone Archivos Espanoles de Urologia 54(7): 739-747
Liu, J-he.; Li, H-wei.; Tong, M.; Li, M.; Na, Y-qun. 2004: Genetic risk factors of prostate cancer in Han nationality population in Northern China and a preliminary study of the reason of racial difference in prevalence of prostate cancer Zhonghua Yi Xue Za Zhi 84(5): 364-368
Perrin, P.; François, O.; Maquet, J.H.; Bringeon, G.; Duteil, P.; Devonec, M. 1991: Circulating prostate cancer specific antigens in benign hypertrophy and localized cancer of the prostate Presse Medicale 20(28): 1313-1319
Fourcade, R-Olivier.; Richaud, P.; Coloby, P.; Malavaud, B. 2007: Role of 150 mg bicalutamide in the treatment of prostate cancer: 3rd analysis of the EPC (early prostate cancer) program Progres en Urologie: Journal de l'Association Francaise d'Urologie et de la Societe Francaise d'Urologie 17(4 Suppl. 1): 891-910
Liu, B.-q.; Wu, Y.-d.; Wei, J.-x.; Zhang, T.; Liu, R.-l.; Ma, T.-x. 2007: Expression of prostate cancer antigen-1 in prostate cancer and its clinical significance Zhonghua Nan Ke Xue 13(11): 997-1001
Kerns, J.William.; Krist, A.H.; Woolf, S.H.; Flores, S.K.; Johnson, R.E. 2008: Patient perceptions of how physicians communicate during prostate cancer screening discussions: a comparison of residents and faculty Family medicine 40(3): 181-187
Sciarra, A.; D'Eramo, G.; Casale, P.; Di Nicola, S.; Di Chiro, C.; De Santis, C.; Loreto, A.; Di Silverio, F. 1999: Penile metastasis from carcinoma of the prostate in a patient with high serum prostate specific antigen levels Minerva Urologica e Nefrologica 51(3): 157-158